Journal of internal medicine
-
Hypercoagulability and thromboembolism are prominent features of severe COVID-19, and ongoing anticoagulant use might be protective. ⋯ Ongoing DOAC use was not associated with reduced risk of severe COVID-19, indicating that prognosis would not be modified by early outpatient DOAC initiation.
-
Editorial Comment
Lemierre syndrome - treat with antibiotics, anticoagulants or both?